blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3319635

EP3319635 - A CHECKPOINT INHIBITOR AND A WHOLE CELL MYCOBACTERIUM FOR USE IN CANCER THERAPY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  25.02.2022
Database last updated on 30.04.2025
FormerThe patent has been granted
Status updated on  19.03.2021
FormerGrant of patent is intended
Status updated on  16.11.2020
FormerExamination is in progress
Status updated on  08.04.2019
FormerRequest for examination was made
Status updated on  13.04.2018
FormerThe international publication has been made
Status updated on  30.12.2016
Most recent event   Tooltip13.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 16.10.2024  [2024/42]
Applicant(s)For all designated states
Immodulon Therapeutics Limited
6-9 The Square
Stockley Park
Uxbridge UB11 1FW / GB
[2018/20]
Inventor(s)01 / AKLE, Charles
Immodulon Therapeutics Limited
6-9 The Square
Stockley Park
Uxbridge UB11 1FW / GB
02 / BRUNET, Laura Rosa
Immodulon Therapeutics Limited
6-9 The Square
Stockley Park
Uxbridge UB11 1FW / GB
 [2018/20]
Representative(s)Gill Jennings & Every LLP
The Broadgate Tower
20 Primrose Street
London EC2A 2ES / GB
[2018/20]
Application number, filing date16734013.224.06.2016
[2018/20]
WO2016GB51893
Priority number, dateGB2015001112024.06.2015         Original published format: GB 201511120
GB2015001112124.06.2015         Original published format: GB 201511121
[2018/20]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016207646
Date:29.12.2016
Language:EN
[2016/52]
Type: A1 Application with search report 
No.:EP3319635
Date:16.05.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 29.12.2016 takes the place of the publication of the European patent application.
[2018/20]
Type: B1 Patent specification 
No.:EP3319635
Date:21.04.2021
Language:EN
[2021/16]
Search report(s)International search report - published on:EP29.12.2016
ClassificationIPC:A61K39/395, C07K16/28, A61K35/74, A61P35/00
[2018/20]
CPC:
A61K35/74 (EP,IL,KR,US); C07K16/2827 (EP,IL,KR,US); A61K39/3955 (IL,KR);
A61K39/39558 (IL,US); A61K39/395 (IL,RU); A61K9/0019 (IL,US);
A61P35/00 (EP,IL,KR,RU,US); A61K2039/505 (EP,IL,KR,US); A61K2039/521 (EP,IL);
A61K2039/54 (EP,IL); A61K2039/545 (EP,IL); A61K2039/585 (EP,IL);
A61K2300/00 (IL,KR); C07K2317/73 (EP,IL); C07K2317/76 (EP,IL) (-)
C-Set:
A61K39/3955, A61K2300/00 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/20]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:CHECKPOINT-INHIBITOR UND GANZZELLIGES MYCOBAKTERIUM ZUR VERWENDUNG IN DER KREBSTHERAPIE[2018/20]
English:A CHECKPOINT INHIBITOR AND A WHOLE CELL MYCOBACTERIUM FOR USE IN CANCER THERAPY[2018/20]
French:INHIBITEUR DE POINT DE VÉRIFICATION ET MYCOBACTÉRIE À GERMES ENTIERS DESTINÉS À UNE UTILISATION DANS LE TRAITEMENT DE CANCER[2018/20]
Entry into regional phase19.12.2017National basic fee paid 
19.12.2017Designation fee(s) paid 
19.12.2017Examination fee paid 
Examination proceduredeletedDeletion: Application deemed to be withdrawn, date of legal effect  [2018/20]
19.12.2017Examination requested  [2018/20]
19.12.2017Date on which the examining division has become responsible
05.03.2018Despatch of communication that the application is deemed to be withdrawn, reason: filing fee / search fee not paid in time  [2018/20]
23.10.2018Amendment by applicant (claims and/or description)
11.04.2019Despatch of a communication from the examining division (Time limit: M06)
18.10.2019Reply to a communication from the examining division
07.04.2020Despatch of a communication from the examining division (Time limit: M04)
09.08.2020Reply to a communication from the examining division
17.11.2020Communication of intention to grant the patent
15.03.2021Fee for grant paid
15.03.2021Fee for publishing/printing paid
15.03.2021Receipt of the translation of the claim(s)
Divisional application(s)EP21167914.7  / EP3868406
Opposition(s)24.01.2022No opposition filed within time limit [2022/13]
Request for further processing for:22.03.2018Request for further processing filed
22.03.2018Full payment received (date of receipt of payment)
Request granted
11.04.2018Decision despatched
Fees paidRenewal fee
27.06.2018Renewal fee patent year 03
25.06.2019Renewal fee patent year 04
12.06.2020Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU24.06.2016
AL21.04.2021
CY21.04.2021
CZ21.04.2021
DK21.04.2021
EE21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
MC21.04.2021
MK21.04.2021
MT21.04.2021
RO21.04.2021
RS21.04.2021
SI21.04.2021
SK21.04.2021
SM21.04.2021
LU24.06.2021
BG21.07.2021
IS21.08.2021
[2024/42]
Former [2024/22]HU24.06.2016
AL21.04.2021
CY21.04.2021
CZ21.04.2021
DK21.04.2021
EE21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
MC21.04.2021
MK21.04.2021
RO21.04.2021
RS21.04.2021
SI21.04.2021
SK21.04.2021
SM21.04.2021
LU24.06.2021
BG21.07.2021
IS21.08.2021
Former [2023/33]HU24.06.2016
AL21.04.2021
CY21.04.2021
CZ21.04.2021
DK21.04.2021
EE21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
MC21.04.2021
RO21.04.2021
RS21.04.2021
SI21.04.2021
SK21.04.2021
SM21.04.2021
LU24.06.2021
BG21.07.2021
IS21.08.2021
Former [2023/30]AL21.04.2021
CY21.04.2021
CZ21.04.2021
DK21.04.2021
EE21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
MC21.04.2021
RO21.04.2021
RS21.04.2021
SI21.04.2021
SK21.04.2021
SM21.04.2021
LU24.06.2021
BG21.07.2021
IS21.08.2021
Former [2022/29]AL21.04.2021
CZ21.04.2021
DK21.04.2021
EE21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
MC21.04.2021
RO21.04.2021
RS21.04.2021
SI21.04.2021
SK21.04.2021
SM21.04.2021
LU24.06.2021
BG21.07.2021
IS21.08.2021
Former [2022/26]AL21.04.2021
CZ21.04.2021
DK21.04.2021
EE21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
MC21.04.2021
RO21.04.2021
RS21.04.2021
SK21.04.2021
SM21.04.2021
LU24.06.2021
BG21.07.2021
IS21.08.2021
Former [2022/23]CZ21.04.2021
DK21.04.2021
EE21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
MC21.04.2021
RO21.04.2021
RS21.04.2021
SK21.04.2021
SM21.04.2021
LU24.06.2021
BG21.07.2021
IS21.08.2021
Former [2022/18]CZ21.04.2021
DK21.04.2021
EE21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
MC21.04.2021
RO21.04.2021
RS21.04.2021
SK21.04.2021
SM21.04.2021
LU24.06.2021
BG21.07.2021
IS22.12.2021
Former [2022/10]CZ21.04.2021
DK21.04.2021
EE21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
MC21.04.2021
RO21.04.2021
RS21.04.2021
SK21.04.2021
SM21.04.2021
BG21.07.2021
IS22.12.2021
Former [2022/09]CZ21.04.2021
DK21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
MC21.04.2021
RO21.04.2021
RS21.04.2021
SK21.04.2021
SM21.04.2021
BG21.07.2021
IS21.08.2021
Former [2022/08]CZ21.04.2021
DK21.04.2021
FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
MC21.04.2021
RS21.04.2021
SM21.04.2021
BG21.07.2021
IS21.08.2021
Former [2022/07]FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
MC21.04.2021
RS21.04.2021
SM21.04.2021
BG21.07.2021
IS21.08.2021
Former [2021/51]FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
RS21.04.2021
BG21.07.2021
IS21.08.2021
Former [2021/49]FI21.04.2021
HR21.04.2021
LT21.04.2021
LV21.04.2021
BG21.07.2021
Former [2021/47]FI21.04.2021
LT21.04.2021
BG21.07.2021
Former [2021/46]FI21.04.2021
LT21.04.2021
Cited inInternational search[A]WO2007050405  (MED COLLEGE GEORGIA RES INST [US], et al);
 [I]US2013209517  (AKLE CHARLES [GB], et al);
 [I]WO2014181121  (IMMODULON THERAPEUTICS [GB]);
 [XPI]WO2015092382  (IMMODULON THERAPEUTICS LTD [GB]);
by applicantWO2006101692
 WO2010027827
 US7799776
 WO2011066342
 US8004449
 US8217149
 WO2012135408
 US2012294796
 US8809562
 US8962804
 US8968388
 WO2015042246
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.